Date(s) - 9 Feb 2021
9:00 AM - 10:30 AM
The ‘Invisible’ Future of Health Monitoring
FEBRUARY 9, 2021
9:00 AM – 10:30 AM MST
If the current pandemic has taught us anything, it is the importance of monitoring not only our own health but the health of our loved ones. It has reiterated the importance of the life science industry to become more digitized and virtually connected as it moves forward.
Fortunately, in the last decade, many in the industry have gotten a head start becoming digitally connected through telehealth tools, wearable devices and more. Providers have been able to remotely monitor their patients, in settings outside of hospitals, receiving health measures from patients back to their providers. Yet, remote monitoring still faces challenges related to adoption, efficacy, and scale. During the current epidemic, remote monitoring efforts have demonstrated its relevance to keep non-emergent patients out of hospitals and clinical care settings, while still monitoring both them and their surroundings.
The question now is how will we as an industry continue to evolve further? Will it give providers a real opportunity to monitor patients? Will ‘invisible health’ monitoring be able to make a real impact on its own, or will the future of connected health be a multi-facetted approach?
Join Johnson & Johnson Innovation -JLABS as they bring together experts in the field to discuss their views on the feasibility of invisible monitoring, the importance of data control and collection, possible impactful use cases, the inevitable concerns that come along with it and the possibilities of health monitoring during the current COVID-19 crisis.
*This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA).